Apolipoprotein E4

Displaying 1 - 8 of 8CSV
Oveisgharan, S., Yu, L., de Paiva Lopes, K., Tasaki, S., Wang, Y., Menon, V., Schneider, J. A., Seyfried, N. T., & Bennett, D. A. (2024). Proteins linking APOE ɛ4 with Alzheimer’s disease. Alzheimer’s & Dementia, 20(7), 4499–4511. Portico. https://doi.org/10.1002/alz.13867
Publication Date
Goldberg, T. E., Devanand, D. P., Fang, Z., Kim, H., Rueppel, E., Tucker, A., Carlson, S., & Lee, S. (2024). Effects of APOE ε4 and Neuropathological Diagnoses on Neuropsychiatric Symptoms: Mediation Analyses and Likely Causation in an Integrated National Alzheimer’s Coordinating Center Database. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 9(7), 650–659. https://doi.org/10.1016/j.bpsc.2024.01.012
Publication Date
Huggins, L. K. L., Min, S. H., Kaplan, S., Wei, J., Welsh-Bohmer, K., & Xu, H. (2023). Meta-Analysis of Variations in Association between APOE ɛ4 and Alzheimer’s Disease and Related Dementias Across Hispanic Regions of Origin. Journal of Alzheimer’s Disease, 93(3), 1095–1109. https://doi.org/10.3233/jad-221167
Publication Date
Columbia Affiliation
Nichols, E., Brickman, A. M., Casaletto, K. B., Dams‐O’Connor, K., George, K. M., Kumar, R. G., Palta, P., Rabin, J. S., Satizabal, C. L., Schneider, J., Pa, J., & La Joie, R. (2022). AD and non‐AD mediators of the pathway between the APOE genotype and cognition. Alzheimer’s & Dementia, 19(6), 2508–2519. Portico. https://doi.org/10.1002/alz.12885
Publication Date
Walsh, C. E., Yang, Y. C., Oi, K., Aiello, A., Belsky, D., Harris, K. M., & Plassman, B. L. (2022). Age Profiles of Cognitive Decline and Dementia in Late Life in the Aging, Demographics, and Memory Study. The Journals of Gerontology: Series B, 77(10), 1880–1891. https://doi.org/10.1093/geronb/gbac038
Publication Date
Seto, M., Weiner, R. L., Dumitrescu, L., Mahoney, E. R., Hansen, S. L., Janve, V., Khan, O. A., Liu, D., Wang, Y., Menon, V., De Jager, P. L., Schneider, J. A., Bennett, D. A., Gifford, K. A., Jefferson, A. L., & Hohman, T. J. (2022). RNASE6 is a novel modifier of APOE-ε4 effects on cognition. Neurobiology of Aging, 118, 66–76. https://doi.org/10.1016/j.neurobiolaging.2022.06.011
Publication Date
Pa, J., Aslanyan, V., Casaletto, K. B., Rentería, M. A., Harrati, A., Tom, S. E., Armstrong, N., Rajan, K., Avila-Rieger, J., Gu, Y., Schupf, N., Manly, J. J., Brickman, A., & Zahodne, L. (2022). Effects of Sex, APOE4, and Lifestyle Activities on Cognitive Reserve in Older Adults. Neurology, 99(8). https://doi.org/10.1212/wnl.0000000000200675
Publication Date
Kim, H., Levine, A., Cohen, D., Gehrman, P., Zhu, X., Devanand, D. P., Lee, S., & Goldberg, T. E. (2022). The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer’s Disease Risks. Journal of Alzheimer’s Disease, 87(4), 1567–1580. https://doi.org/10.3233/jad-215417
Publication Date